Tennessee Warns Christa Pike Drug Inspection Could Halt Executions

Tennessee officials warn that allowing Christa Pike's attorneys to examine the drugs used in her failed execution could force the state to halt future lethal injections if its pentobarbital supplier cuts off access.

In a November 6, 2026, court filing, Tennessee Attorney General Jonathan Skrmetti asked Davidson County Chancellor I'Ashea L. Myles to block Pike's legal team from inspecting, collecting or testing pentobarbital left over from the September 30 execution attempt. The state argues that information on the drug vials could expose the supplier's identity, which Tennessee law protects from public disclosure.

An unnamed Tennessee Department of Correction employee said in a sworn statement that the supplier had warned it would stop providing the drug if identified. The employee added that finding another source would be unlikely, potentially leaving Tennessee unable to carry out executions using pentobarbital.

Another supplier stopped communicating with corrections officials in 2024 after its identity became known, according to the affidavit. The current provider has expressed concern that even partially redacted vial labels could reveal identifying information.

Skrmetti's request would revise an October 10 order requiring Tennessee to preserve evidence from Pike's unsuccessful execution, including drugs, syringes and intravenous equipment. Myles granted Pike's attorneys access to remaining lethal injectionlethal injectionLethal injection is a method of carrying out a death sentence by administering one or more drugs intended to cause death. Lethal injection protocols are governed by state or federal law and can be challenged under the Eighth Amendment if the procedure allegedly creates an unconstitutional risk of severe pain.Read more → substances, a provision the state now wants removed while maintaining the broader preservation requirements.

The dispute follows Pike's survival of two doses of pentobarbital at Riverbend Maximum Security Institution. Her attorneys allege that repeated attempts to establish intravenous access damaged her veins, causing the drug to collect in surrounding tissue rather than enter her bloodstream.

According to court filings, the execution team used approximately 10 needles while attempting to establish intravenous access in both arms. Pike's attorneys say the procedure left her with burns and blisters before she was transported to a hospital, where she required a ventilator.

Pike's attorneys are seeking information about how the pentobarbital was labeled, mixed, transported and stored, including whether it had expired. Attorney Luke Ihnen has disputed the state's suggestion that the legal team intends to identify the supplier.

The requested examination would allow Pike's attorneys to investigate whether problems with the drug's preparation, storage or administration contributed to the failed execution.

The September execution failure led to the resignation of Tennessee's corrections commissioner, an independent review of the procedure and the postponement of another scheduled lethal injection.

Myles has yet to issue a publicly confirmed ruling on Tennessee's November 6 request. The existing preservation order remains at the center of the dispute over access to the remaining pentobarbital.